Decoy Therapeutics Inc. DCOY
1.12 USD +0.02 (+1.82%)
Nov 10, 2026, 1:23 PM EST
1.00 Day range 1.13
0.90 52-week range 20.76
- YTD
- -85.62%
- 1 year
- -95.33%
- Market cap
- 2.71M
- EPS (ttm)
- 12.74
- P/E ratio
- 0.09
- YTD return
- -85.62%
- 1-year return
- -95.33%
- Volume
- 34.02K
- Avg volume
- 2.16M
- Open
- 1.10
- Previous close
- 1.10
- Day's range
- 1.00 – 1.13
- 52-week range
- 0.90 – 20.76
5D +0.05 (+4.63%)
Financials — quick view
DCOY Revenue — quarterly 227.63K
DCOY Net income — quarterly -2.37M
DCOY EPS — quarterly -4.46
News
Decoy Therapeutics Named “R&D Solution of the Year” in 2026 BioTech Breakthrough Awards 
Decoy Therapeutics Provides Third Quarter 2026 Business Update 
12 Health Care Stocks Moving In Monday's Intraday Session 
12 Health Care Stocks Moving In Wednesday's Intraday Session - 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Why Worthington Enterprises Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket 
12 Health Care Stocks Moving In Tuesday's After-Market Session 
Crude Oil Down Over 1%; Thor Industries Shares Gain After Q4 Results - 12 Health Care Stocks Moving In Tuesday's Intraday Session
Decoy Therapeutics To Exercise 1,184,434 Series B Warrants At $3.25/Share for ~$3.85M; Cuts Series A & C Warrant Prices To $3.25 And Issues 2,368,868 New Warrants At $3.25/Share
Your note
Sign in to keep a note on DCOY — it syncs with the Stock Master app.